Nova Vaccine Rad began its operations in 2021 with the goal of achieving self-sufficiency and reducing the poultry industry’s dependence on imported vaccines, as well as producing recombinant vaccines tailored to the circulating strains in the country, with high quality, efficacy, and competitive pricing. Starting with the production of a highly pathogenic avian influenza vaccine, the company succeeded within just one year in supplying 70% of the country’s demand for avian influenza vaccines in industrial poultry farms.